Trademark Overview
On Tuesday, March 17, 2026, a trademark application was filed for CONTRA-MAB with the United States Patent and Trademark Office. The USPTO has given the CONTRA-MAB trademark a serial number of 99706801. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 17, 2026. This trademark is owned by INHIBRX BIOSCIENCES, INC.. The CONTRA-MAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Discovery and development of engineered modular protein formats; Discovery and development of new drug candidate material; Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals; Discovery, research, and development services in the field of pharmaceutical preparations and substances; Discovery, research, and development of therapeutic antibodies and pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical, therapeutic, and diagnostic drug discovery services; Medical research in the nature of engineered modular protein formats
